Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D0X8ZO | ||||
| Former ID | DNC013504 | ||||
| Drug Name | 1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [529193] | ||
| Formula | C18H26N2O2 | ||||
| Canonical SMILES | CCCCCCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2 | ||||
| InChI | 1S/C18H26N2O2/c1-2-3-4-5-6-7-8-9-10-12-15(21)18-20-17-16(22-18)13-11-14-19-17/h11,13-14H,2-10,12H2,1H3 | ||||
| InChIKey | XUWBDQAPIZBSRY-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529193] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
